0001948657-26-000002.txt : 20261030 0001948657-26-000002.hdr.sgml : 20261030 20261030115657 ACCESSION NUMBER: 0001948657-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20261030 DATE AS OF CHANGE: 20261030 EFFECTIVENESS DATE: 20261030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Epsilon Healthcare Innovation Fund II, LP CENTRAL INDEX KEY: 0001948657 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-465330 FILM NUMBER: 261505895 BUSINESS ADDRESS: STREET 1: 1227 25TH STREET NW STE 700 CITY: WASHINGTON STATE: DC ZIP: 20037 BUSINESS PHONE: 2026027213 MAIL ADDRESS: STREET 1: 1227 25TH STREET NW STE 700 CITY: WASHINGTON STATE: DC ZIP: 20037 D/A 1 primary_doc.xml X0708 D/A LIVE 0001948657 Epsilon Healthcare Innovation Fund II, LP 1227 25TH STREET NW STE 700 Washington DC DISTRICT OF COLUMBIA 20037 2026027213 DELAWARE None None Limited Partnership true 2022 Gregory Epstein Epsilon Healthcare Innovation Fund II LP 1227 25TH STREET NW STE 700 Washington DC DISTRICT OF COLUMBIA 20037 Executive Officer Director Manager of Epsilon Healthcare Innovation Fund II GP LLC, the General Partner of Issuer Stevens Brady Epsilon Healthcare Innovation Fund II LP 1227 25TH STREET NW STE 700 Washington DC DISTRICT OF COLUMBIA 20037 Executive Officer Officer of General Partner of Issuer Steven Epstein Epsilon Healthcare Innovation Fund II LP 1227 25TH STREET NW STE 700 Washington DC DISTRICT OF COLUMBIA 20037 Executive Officer Director Manager of General Partner of Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 3C.1 true 0001948657-25-000003 2022-12-01 true true true true General Partner discretion to accept different minimum investment amount. false 100000 50000000 17550000 32450000 false 25 0 0 1000000 true Estimated management fees payable during 1st year of the investment period of the Issuer based on aggregate commitments of $50,000,000. Add'l fees are payable for remainder of term of Issuer described in the confidential offering materials of the Issuer. false Epsilon Healthcare Innovation Fund II, LP /s/ Stevens Andrew Brady Stevens Andrew Brady Officer of the General Partner of Issuer 2026-10-29